Ad. Baxter et al., A NOVEL SERIES OF MATRIX METALLOPROTEINASE INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISORDERS, Bioorganic & medicinal chemistry letters, 7(7), 1997, pp. 897-902
The preparation of a novel series of matrix metalloproteinase inhibito
rs is described, based on the use of a mercaptoacyl zinc binding moiet
y. The compounds have been tested in a model of rheumatoid arthritis a
nd show good oral activity. (C) 1997 Elsevier Science Ltd.